Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 8/8/2022
Risk of myopericarditis with Pfizer COVID-19 vaccine in children 5 to 11 years
Danish study examines risk of myopericarditis after COVID-19 vaccination in children, compared with adolescents and background incidence. - 8/3/2022
Albrioza now available for the treatment of ALS in Canada
Oral fixed-dose combination therapy may reduce neuronal cell death in adults with amyotrophic lateral sclerosis - 8/1/2022
Levonorgestrel double dose inadequate for emergency contraception in women with obesity
Ulipristal acetate may be a better oral emergency contraceptive choice in women who weigh more than 70 kg. - 7/27/2022
Latest drug indications: Key updates for June/July
Our clinical writer Lu-Ann Murdoch keeps up to date on all the latest drug news in Canada. This summer she's highlighted many new indications for existing drugs including Zeposia, Jardiance and Gardasil 9. - 7/27/2022
First saliva-based portable PCR test for SARS-CoV-2 authorized by Health Canada
Noninvasive testing procedure offers polymerase chain reaction (PCR) accuracy, with results provided in fewer than 30 minutes. - 7/26/2022
Significant number of children experience post-COVID-19 conditions
Study examines risk of developing post–COVID-19 conditions in children 90 days after SARS-CoV-2 infection. - 7/25/2022
New products: Latest drug releases for June/July
Our clinical writer Lu-Ann Murdoch keeps up to date on all the latest drug news in Canada. This summer she's highlighted three new launches including an atypical antipsychotic, a therapy for plaque psoriasis and pre-exposure prophylaxis for COVID-19. - 7/20/2022
WHO recommends against using fluvoxamine for non-severe COVID-19
Use should be restricted to clinical trials; other options are recommended for non-severe COVID-19, including nirmatrelvir–ritonavir (Paxlovid) and remdesivir. - 7/20/2022
POP QUIZ: Climate change
A recent article focused on how pharmacists can tackle climate change. All of the following pharmacy-related actions can help to reduce or manage the impact of climate change, EXCEPT for: - 7/18/2022
Study examines systemic reaction rates with concurrent COVID-19 and flu vaccines
Giving both vaccines at the same visit increases the rate of systemic adverse effects by 8% to 11% compared to giving an mRNA COVID-19 booster alone.
